Matches in DBpedia 2016-04 for { ?s ?p "Jaap Goudsmit (b. Amsterdam, 22 July 1951) is Dutch scientist, known for his research in the field of AIDS.In 1978 Jaap Goudsmit received his MD degree with honor at the Faculty of Medicine of the University of Amsterdam. He was awarded a Fogarty fellowship, and joined the research on kuru with Nobel Prize winner Daniel Carleton Gajdusek. He received his PhD from the University of Amsterdam in 1982. He received a Fogarty Visiting Scientist Award to do postdoctoral research at the National Institutes of Health in Bethesda, Maryland. In 1983 Jaap Goudsmit became board certified in the Netherlands as a Medical Microbiologist. In 1989 he became professor in virology at the University of Amsterdam. In 1990 he was involved in a controversy in a research project to use antisense as a means of inhibiting HIV-replication.Jaap Goudsmit has been head of the Department of Human Retrovirology at the Academic Medical Center (AMC) of the University of Amsterdam from 1996 to 2002 and chairman of the AMC Research Institute for Infectious Diseases and the AMC Institute for Science Education. Since 1984 he is one of the principal researcher of the Amsterdam Cohort Studies on HIV infection and AIDS among homosexual men and HIV drug users.He is the founder of PrimaGen, the first biotech company concentrating on predictive medicine. He chaired the Scientific Advisory Committee of the International AIDS Vaccine Initiative (IAVI) and has been a member of its board. He was project leader and (co)chair of Eurovacc Foundation. In 2002 Jaap Goudsmit joined Crucell, a biotechnology company in Leiden, as Chief Medical Officer and Executive Vice President of Vaccine Research and Development. In 2003 he was elected as member of the HIV Vaccine Enterprise Product Development Working Group of the Gates Foundation and in 2006 he was affiliated with Pevion Biotech as member of the Supervisory Board. In 2006 Jaap Goudsmit entered the board of Vaxin Inc.Goudsmit is a very productive researcher and author or co-author of more than 450 scientific publications. According to the Institute for Scientific Information, he entered the list of most-cited scientists in 2001."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Jaap_Goudsmit abstract "Jaap Goudsmit (b. Amsterdam, 22 July 1951) is Dutch scientist, known for his research in the field of AIDS.In 1978 Jaap Goudsmit received his MD degree with honor at the Faculty of Medicine of the University of Amsterdam. He was awarded a Fogarty fellowship, and joined the research on kuru with Nobel Prize winner Daniel Carleton Gajdusek. He received his PhD from the University of Amsterdam in 1982. He received a Fogarty Visiting Scientist Award to do postdoctoral research at the National Institutes of Health in Bethesda, Maryland. In 1983 Jaap Goudsmit became board certified in the Netherlands as a Medical Microbiologist. In 1989 he became professor in virology at the University of Amsterdam. In 1990 he was involved in a controversy in a research project to use antisense as a means of inhibiting HIV-replication.Jaap Goudsmit has been head of the Department of Human Retrovirology at the Academic Medical Center (AMC) of the University of Amsterdam from 1996 to 2002 and chairman of the AMC Research Institute for Infectious Diseases and the AMC Institute for Science Education. Since 1984 he is one of the principal researcher of the Amsterdam Cohort Studies on HIV infection and AIDS among homosexual men and HIV drug users.He is the founder of PrimaGen, the first biotech company concentrating on predictive medicine. He chaired the Scientific Advisory Committee of the International AIDS Vaccine Initiative (IAVI) and has been a member of its board. He was project leader and (co)chair of Eurovacc Foundation. In 2002 Jaap Goudsmit joined Crucell, a biotechnology company in Leiden, as Chief Medical Officer and Executive Vice President of Vaccine Research and Development. In 2003 he was elected as member of the HIV Vaccine Enterprise Product Development Working Group of the Gates Foundation and in 2006 he was affiliated with Pevion Biotech as member of the Supervisory Board. In 2006 Jaap Goudsmit entered the board of Vaxin Inc.Goudsmit is a very productive researcher and author or co-author of more than 450 scientific publications. According to the Institute for Scientific Information, he entered the list of most-cited scientists in 2001.".
- Q2346715 abstract "Jaap Goudsmit (b. Amsterdam, 22 July 1951) is Dutch scientist, known for his research in the field of AIDS.In 1978 Jaap Goudsmit received his MD degree with honor at the Faculty of Medicine of the University of Amsterdam. He was awarded a Fogarty fellowship, and joined the research on kuru with Nobel Prize winner Daniel Carleton Gajdusek. He received his PhD from the University of Amsterdam in 1982. He received a Fogarty Visiting Scientist Award to do postdoctoral research at the National Institutes of Health in Bethesda, Maryland. In 1983 Jaap Goudsmit became board certified in the Netherlands as a Medical Microbiologist. In 1989 he became professor in virology at the University of Amsterdam. In 1990 he was involved in a controversy in a research project to use antisense as a means of inhibiting HIV-replication.Jaap Goudsmit has been head of the Department of Human Retrovirology at the Academic Medical Center (AMC) of the University of Amsterdam from 1996 to 2002 and chairman of the AMC Research Institute for Infectious Diseases and the AMC Institute for Science Education. Since 1984 he is one of the principal researcher of the Amsterdam Cohort Studies on HIV infection and AIDS among homosexual men and HIV drug users.He is the founder of PrimaGen, the first biotech company concentrating on predictive medicine. He chaired the Scientific Advisory Committee of the International AIDS Vaccine Initiative (IAVI) and has been a member of its board. He was project leader and (co)chair of Eurovacc Foundation. In 2002 Jaap Goudsmit joined Crucell, a biotechnology company in Leiden, as Chief Medical Officer and Executive Vice President of Vaccine Research and Development. In 2003 he was elected as member of the HIV Vaccine Enterprise Product Development Working Group of the Gates Foundation and in 2006 he was affiliated with Pevion Biotech as member of the Supervisory Board. In 2006 Jaap Goudsmit entered the board of Vaxin Inc.Goudsmit is a very productive researcher and author or co-author of more than 450 scientific publications. According to the Institute for Scientific Information, he entered the list of most-cited scientists in 2001.".